Doug Hampton

Biopharma’s Perceptions of Thought Leadership of Global Contract Research Organizations (CROs) Featuring Covance, ICON, IQVIA, Labcorp, Medpace, Parexel, PPD, PRA, Syneos, & Thermo Fisher Scientific

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Biopharma Perceptions of Global CRO Thought Leadership – 2023” report has been added to ResearchAndMarkets.com’s offering. The report examines perceptions of 120 professionals across emerging, small, mid-size and large biopharmaceutical companies in North America and Europe involved in outsourcing clinical development services to the leading, global CROs. This report … Read more

MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE

by

SUZHOU, China, June. 16, 2023  /PRNewswire/ — The 4th Academic Annual Conference held by the Mechanical Circulatory Support (MCS) Branch of the Chinese Society of Biomedical Engineering (CSBE), one of the biggest academic gatherings that celebrate the latest accomplishments in technological innovation for improving human health, witnessed the display of the MoyoAssist® Extra-VAD – a fully … Read more

South Korea In-Vitro Diagnostics (IVD) Market Report 2023: A $3.7 Billion Market by 2028

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Government Initiatives, Recent Developments – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. South Korea In-Vitro Diagnostics (IVD) market is predicted to reach US$ 3.7 Billion by 2028 … Read more

Formulation Technologies & Platforms, Physical Process Control Methods, Development Factors, Competitive Landscape

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Extended Release Injectable Drugs” report has been added to ResearchAndMarkets.com’s offering. Chronic conditions require drug administration over long periods of time, placing a greater emphasis on self-administration. With the shift away from caregiver interaction, drug safety and compliance/adherence become prominent concerns. These concerns, which are not new, are becoming … Read more

Wider Search Needed to Better Treat Eosinophilic Food Allergy

by

Eliminating eosinophils not enough to improve outcomes for eosinophilic gastritis. Tweet this These paradigm-shifting Phase 2 clinical trial results were published online June 16, 2023, in The Lancet Gastroenterology & Hepatology. “Our findings suggest that the mechanisms driving this disease are in large part independent of excessive eosinophil production. That means our attention should turn … Read more

Ipsen acaba de aprovar Bylvay® no Brasil, após a conclusão da aquisição da Albireo

by

A aprovação dessa droga, fruto da aquisição da Albireo,  representa uma oportunidade de crescimento para a Ipsen e reforça o seu posicionamento no mercado de doenças raras São Paulo, 16 de junho de 2023 /PRNewswire/ — A Ipsen acaba de aprovar o Bylvay® (odevixubate) no Brasil e o seu registro foi publicado no Diário Oficial … Read more

Demand for Natural Vitamin E is Projected to Reach About 20K Metric Tons by 2028

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Natural Source Vitamin E (Tocopherols and Tocotrienols) – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. Global demand for Natural Source Vitamin E reached US$1.1 billion in 2022, registering a YOY growth of 17% attributed to huge price increase in Tocopherols.  Dietary Supplements sector is the … Read more

Look at more than 550 Drugs in Clinical Trial

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Global Cancer Antibody Drug Conjugates Market Size, Drug Sales, Drug Dosage, Price, & Clinical Trials Outlook 2029” report has been added to  ResearchAndMarkets.com’s offering. Global Cancer Antibody Drug Conjugates Market Size, Drug Sales, Drug Dosage, Price, & Clinical Trials Outlook 2029 Report Highlights: Global Antibody Drug Conjugates Market Opportunity: … Read more

Cano Health Announces Leadership Change to Advance Execution of Value Creation Plan

by

Mark Kent appointed Interim Chief Executive Officer Dr. Marlow Hernandez has agreed to step down immediately as Chief Executive Officer and remain on the Board of Directors Launches search to identify permanent CEO and to refresh the Board with additional new independent directors MIAMI, June 16, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or … Read more

SQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy Filing

by

TORONTO, June 16, 2023 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF) today announced that the Company’s board of directors (the “Board“) has received a notice of intention (the “Notice“) to enforce security issued by its senior secured creditor, Pivot Financial I Limited Partnership (“Pivot“), under Section 244(1) of the Bankruptcy and … Read more